ArticleFrontiers in cardiovascular medicine2025
Relationship between epicardial adipose tissue volume and atrial fibrillation in patients with rheumatoid arthritis.
Article in Frontiers in cardiovascular medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- A narrative review of epicardial adipose tissue as a predictor of cardiometabolic risk in rheumatoid arthritis patients.Annals of translational medicine · 2025Review
- Arrhythmias in Rheumatoid Arthritis: A Call for a Multidisciplinary Team.Life (Basel, Switzerland) · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Epicardial adipose tissue (EAT) is involved in cardiac inflammatory responses and has been associated with both atrial fibrillation (AF) and rheumatoid arthritis (RA). However, the condition of EAT in patients with both RA and AF is still unclear. In addition, the risks of stroke and bleeding in patients with both RA and AF are unknown. Methods: A retrospective analysis was conducted in patients with RA aged ≥18 years from August 2021 to May 2023, and compared with age- and gender-matched patients without RA. The volume of EAT was measured using chest computed tomography and the EAT/body mass index (BMI) ratio was used to correct for the possible impact of BMI differences. The stroke and bleeding risks of the patients were assessed using the CHA Results: A total of 145 patients with RA and 282 patients without RA were included. The volume of EAT or EAT/BMI ratio was similar between the patients with RA and no AF and those without both RA and AF. Compared to the patients without AF, those with AF had a larger EAT volume or EAT/BMI ratio, regardless of whether they had RA or not. EAT/BMI ratio was significantly associated with left atrial (LA) diameter among the patients with RA (RR = 2.23, Conclusion: LA diameter correlates with the EAT/BMI ratio in patients with RA who exhibit larger LA-EAT volume and LA-EAT/total EAT ratios compared to individuals without RA.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.